Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous tranexamic acid dose comparison for blood loss after term vaginal delivery
PACTR202310814099421Not yet recruiting
- Start
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of tranexamic acid in postpartum hemorrhage (PPH). Primary endpoint: mean blood loss. Planned start Jan 2024; status: not yet recruiting.
02
Drugs
tranexamic acid
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on PACTR202310814099421.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202310814099421.